Brentuximab vedotin in the frontline setting

Cetuximab superior to bevacizumab for advanced colorectal cancer

Nivolumab produces long-lasting responses in patients with stage IV melanoma

Maintenance therapy with multi-targeted drug pazopanib delays relapse of advanced ovarian cancer

Adding GM-CSF to ipilimumab improves survival compared to ipilimumab alone

Treatment of primary central nervous system germinoma with chemotherapy

Biomarker analyses in emerging data from PI3K/AKT/mTOR programme clinical trials

Integrating breast cancer genomics and proteomics

Using chemo-radiotherapy without increasing toxicity

Approaches to treatment of brain metastasis

Sapacitabine and seliciclib, antitumour activity in patients with incurable BRCA-deficient cancers

Durable survival benefit for thalidomide consolidation in multiple myeloma post ASCT